Our latest thinking, insights and company news

Never miss an update, subscribe today.

RJW&partners will only use your personal information to administer your account and provide the products and services you request. You can unsubscribe at any time, to do so please review our Privacy Policy. By clicking subscribe, you consent to allow RJW&partners to store and process your personal information.

Jan 6
2 min

Helen Johnson joins RJW&partners as Director

We are delighted to announce the appointment of Helen Johnson as Director.

205 views

Dec 17, 2021
10 min

What have NICE and NHS England been up to in 2021?

A summary of some of the key changes and announcements made by NICE and NHS England and NHS Improvement during 2021

56 views

Sep 6, 2021
5 min

How copay accumulators and maximizers are shifting drug costs to patients and manufacturers

Recently, healthcare insurance companies and PBMs have been leveraging two new strategies that shift further costs onto commercially-covered

163 views

Jun 28, 2021
4 min

The management of orphan drug prices after loss of exclusivity

What happens to orphan drugs when they lose market exclusivity? Do they face generic competition and price reductions like other drugs?...

262 views

Jun 8, 2021
4 min

Biden and big change: is he just getting started?

Biden has unveiled his proposed 2022 budget, which reveals his healthcare policy priorities but lacks financial details.

35 views

Jun 2, 2021
5 min

Biosimilar uptake: will the US catch up with Europe?

Uptake of biosimilars has been much slower in the US compared to Europe. Could recent and upcoming reforms change this?

63 views